These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 22874850)
1. A phase III, randomized controlled study to assess the safety and immunogenicity of a semi-synthetic diphtheria, tetanus and whole-cell pertussis vaccine in Indian infants. Sharma H; Patil V; Sharma D; Kapre S; Jadhav S; Ravetkar S; Kumar R; Bahl S; Parekh S; Chakravarty A Vaccine; 2012 Sep; 30(43):6157-62. PubMed ID: 22874850 [TBL] [Abstract][Full Text] [Related]
2. A phase III randomized, controlled study to assess and compare the immunogenicity and tolerability of single and multi-dose vials of DTwP-Hib, a fully liquid quadravalent vaccine and their comparison with TETRAct-Hib vaccine in Indian infants aged 6-14 weeks. Sharma H; Yadav S; Patil V; Chacko B; Kapre S; Jadhav S; Ravetkar S; Bahl S; Parekh S; Chakravarty A; Ashtagi G; Prasath A Vaccine; 2011 Nov; 29(48):8773-9. PubMed ID: 21968445 [TBL] [Abstract][Full Text] [Related]
3. Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 15- through 20-month-old infants. Bernstein HH; Rothstein EP; Reisinger KS; Blatter MM; Arbeter AM; Fontana ME; Jacobs JM; Long SS; Rathfon H; Crayne O Pediatrics; 1994 Apr; 93(4):656-9. PubMed ID: 8134224 [TBL] [Abstract][Full Text] [Related]
4. Acellular pertussis vaccine boosters combined with diphtheria and tetanus toxoid boosters for adolescents: safety and immunogenicity assessment when preceded by different 5-dose DTaP/DTwP schedules. Pichichero ME; Casey JR; Francis AB; Marsocci SM; Murphy M; Hoeger W; Cleary C Clin Pediatr (Phila); 2006 Sep; 45(7):613-20. PubMed ID: 16928838 [TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea. Lee SY; Hwang HS; Kim JH; Kim HH; Lee HS; Chung EH; Park SE; Ma SH; Chang JK; Guitton F; Ortiz E; Kang JH Vaccine; 2011 Feb; 29(8):1551-7. PubMed ID: 21215828 [TBL] [Abstract][Full Text] [Related]
6. Primary immunization with a triple diphtheria-tetanus-whole cell pertussis vaccine in Iranian infants: an analysis of antibody response. Zarei S; Jeddi-Tehrani M; Akhondi MM; Zeraati H; Pourheidari F; Ostadkarampour M; Tavangar B; Shokri F Iran J Allergy Asthma Immunol; 2009 Jun; 8(2):85-93. PubMed ID: 19671937 [TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of two diphtheria-tetanus-whole cell pertussis-hepatitis B vaccines in infants: a comparative trial. Kulkarni PS; Sapru A; Bavdekar A; Naik SS; Patwardhan M; Barde P; Pandit AN Hum Vaccin; 2011 Sep; 7(9):941-4. PubMed ID: 21921700 [TBL] [Abstract][Full Text] [Related]
8. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period. Miller MA; Meschievitz CK; Ballanco GA; Daum RS Pediatrics; 1995 Apr; 95(4):522-7. PubMed ID: 7700752 [TBL] [Abstract][Full Text] [Related]
9. Primary vaccination of infants with diphtheria-tetanus-acellular pertussis-hepatitis B virus- inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections. Schmitt HJ; Knuf M; Ortiz E; Sänger R; Uwamwezi MC; Kaufhold A J Pediatr; 2000 Sep; 137(3):304-12. PubMed ID: 10969252 [TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of a triple diphtheria-tetanus-whole cell pertussis vaccine in Iranian preschool children. Zarei S; Jeddi-Tehrani M; Akhondi MM; Zeraati H; Kheirkhah T; Ghazanfari M; Shokri F Iran J Immunol; 2007 Jun; 4(2):101-9. PubMed ID: 17652850 [TBL] [Abstract][Full Text] [Related]
11. Safety and immunogenicity of Haemophilus influenzae type B vaccine given in combination with DTwP at 6, 10 and 14 weeks of age. Cherian T; Thomas N; Raghupathy P; Durot I; Dutta A Indian Pediatr; 2002 May; 39(5):427-36. PubMed ID: 12037271 [TBL] [Abstract][Full Text] [Related]
12. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content. Hla KH; Thein SA; Aye A; Han HH; Bock HL; David MP; Schuerman L Pediatr Infect Dis J; 2006 Aug; 25(8):706-12. PubMed ID: 16874170 [TBL] [Abstract][Full Text] [Related]
13. Assessment of safety and immunogenicity of two different lots of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine manufactured using small and large scale manufacturing process. Sharma HJ; Patil VD; Lalwani SK; Manglani MV; Ravichandran L; Kapre SV; Jadhav SS; Parekh SS; Ashtagi G; Malshe N; Palkar S; Wade M; Arunprasath TK; Kumar D; Shewale SD Vaccine; 2012 Jan; 30(3):510-6. PubMed ID: 22119927 [TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses. Halperin SA; King J; Law B; Mills E; Willems P Clin Infect Dis; 1999 May; 28(5):995-1001. PubMed ID: 10452624 [TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants. Punjabi NH; Richie EL; Simanjuntak CH; Harjanto SJ; Wangsasaputra F; Arjoso S; Rofiq A; Prijanto M; Julitasari ; Yela U; Herzog C; Cryz SJ Vaccine; 2006 Mar; 24(11):1776-85. PubMed ID: 16303216 [TBL] [Abstract][Full Text] [Related]
16. Can Haemophilus influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid-pertussis vaccine-tetanus toxoid? Scheifele D; Barreto L; Meekison W; Guasparini R; Friesen B CMAJ; 1993 Oct; 149(8):1105-12. PubMed ID: 8221449 [TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age. Nolan T; Bernstein H; Blatter MM; Bromberg K; Guerra F; Kennedy W; Pichichero M; Senders SD; Trofa A; Collard A; Sullivan DC; Descamps D Pediatrics; 2006 Sep; 118(3):e602-9. PubMed ID: 16950952 [TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity of a diphtheria, tetanus, acellular pertussis and Haemophilus influenzae Type b combination vaccine compared with separate administration of licensed equivalent vaccines in Chinese infants and toddlers for primary and booster immunization. Li G; Zhang H; Zhou W; Ye Q; Li F; Wang H; Hou Q; Xu Y; Ma X; Tan Y; Wang L; Li Y; Li H; Meng F; Liang Q; Liu A; Qin C; Wei W; Liu J; Ruan C; Tao W; Zhang S; Zheng H; Zhu F Vaccine; 2010 Jun; 28(25):4215-23. PubMed ID: 20399240 [TBL] [Abstract][Full Text] [Related]
19. A cellular pertussis vaccine (Infanrix-DTPa; SB-3). A review of its immunogenicity, protective efficacy and tolerability in the prevention of Bordetella pertussis infection. Patel SS; Wagstaff AJ Drugs; 1996 Aug; 52(2):254-75. PubMed ID: 8841742 [TBL] [Abstract][Full Text] [Related]
20. Diphtheria-tetanus-acellular pertussis vaccine adsorbed (Triacelluvax; DTaP3-CB): a review of its use in the prevention of Bordetella pertussis infection. Matheson AJ; Goa KL Paediatr Drugs; 2000; 2(2):139-59. PubMed ID: 10937466 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]